L'Oréal is expanding its medical aesthetics reach with investments in med-spa operators SkinSpirit and YesSkin.
L’Oréal is increasing its exposure to the medical aesthetics sector, taking a more active role in the clinic businesses connecting professional skincare with injectable and other aesthetic treatments.
Strategic investments across three markets
The group is building a strong portfolio of investments in medical spa operators across three major markets. These include a 36.13% holding in US clinic group SkinSpirit, a 70% controlling interest in Chinese aesthetics operator YesSkin, and an investment in Canadian Functionalab Group through its venture capital arm, BOLD.
The investments form part of a wider move by L’Oréal to strengthen its presence across the professional aesthetics market, bringing its skincare expertise closer to the practitioners delivering in-clinic treatments.
Linking clinical treatments with professional skincare
L’Oréal CEO Nicolas Hieronimus discussed the commercial potential of the sector during the company's third-quarter earnings call in October, explaining that its clinic investments provide a direct understanding of the treatments consumers are seeking and the products they use alongside them.
This is particularly relevant for SkinCeuticals, L’Oréal's professional skincare brand, which generated more than $1.1 billion in annual sales in 2025. The company sees opportunities to connect clinical treatments with specialist skincare, as consumers increasingly look to maintain and improve results through their at-home routines.
Medical aesthetics market continues to grow
The growing overlap between these markets is supported by rising demand for medical aesthetics. The US med-spa industry is now worth more than $17 billion annually, compared with approximately $15 billion in 2022, and is estimated to be expanding by 5–8% a year.
Research also points to an increasingly integrated approach to beauty, with consumers combining professional skincare, medical treatments and wider wellness services rather than viewing them as separate categories.
What does this mean for aesthetic and beauty professionals?
For clinic and salon owners and operators, and professional skincare brands, L’Oréal's growing involvement is a notable development. It demonstrates the increasing commercial importance of the relationship between treatment services, practitioner-led product recommendations and ongoing skincare retail.
As major beauty groups look more closely at medical aesthetics, the sector is also likely to attract further investment. However, maintaining clinical standards, qualified practitioners and patient confidence will remain essential as the market expands.